IO Biotech Inc (IOBT)
0.8538
-0.12
(-11.98%)
USD |
NASDAQ |
Nov 14, 16:00
0.88
+0.03
(+3.07%)
After-Hours: 20:00
IO Biotech Total Liabilities (Quarterly): 15.20M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 15.20M |
| March 31, 2024 | 12.69M |
| December 31, 2023 | 17.56M |
| September 30, 2023 | 14.96M |
| June 30, 2023 | 13.04M |
| March 31, 2023 | 12.63M |
| December 31, 2022 | 12.95M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.668M |
| June 30, 2022 | 10.47M |
| March 31, 2022 | 8.478M |
| December 31, 2021 | 10.36M |
| September 30, 2021 | 71.69M |
| June 30, 2021 | 76.86M |
| December 31, 2020 | 40.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.478M
Minimum
Mar 2022
76.86M
Maximum
Jun 2021
23.32M
Average
12.99M
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co Inc | 72.97B |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 111.47M |
| Shareholders Equity (Quarterly) | 96.27M |